ID: ALA201837

Max Phase: Preclinical

Molecular Formula: C13H18N2O2

Molecular Weight: 234.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(N2CCN(C(C)=O)CC2)cc1

Standard InChI:  InChI=1S/C13H18N2O2/c1-11(16)14-7-9-15(10-8-14)12-3-5-13(17-2)6-4-12/h3-6H,7-10H2,1-2H3

Standard InChI Key:  AVCQLYXAEKNILW-UHFFFAOYSA-N

Associated Targets(non-human)

Large conductance calcium-activated potassium channel 44 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 234.30Molecular Weight (Monoisotopic): 234.1368AlogP: 1.36#Rotatable Bonds: 2
Polar Surface Area: 32.78Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.99CX LogP: 1.00CX LogD: 1.00
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.77Np Likeness Score: -1.32

References

1. Power EC, Ganellin CR, Benton DC..  (2006)  Partial structures of ketoconazole as modulators of the large conductance calcium-activated potassium channel (BK(Ca)).,  16  (4): [PMID:16359866] [10.1016/j.bmcl.2005.11.001]

Source